Jorge Alberto Aguilar-Pineda

Dr. Jorge Alberto Aguilar-Pineda

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2019 in Journal of Molecular Modeling
Verified
Journal Article
Closed access
PDF file
CPCarla A. Paredes-Rosan
Carla A. Paredes-Rosan
DVDiego E. Valencia
Diego E. Valencia
Haruna L. Barazorda-CcahuanaHaruna L. Barazorda-Ccahuana
Haruna L. Barazorda-Ccahuana
JAJorge Alberto Aguilar-Pineda
Jorge Alberto Aguilar-Pineda
Badhin GómezBadhin Gómez
Badhin Gómez

2 October 2018 in Journal of Chemical Theory and Computation
Verified
Journal Article
Closed access
ALAlexander Pérez de la Luz
Alexander Pérez de la Luz
JAJorge Alberto Aguilar-Pineda
Jorge Alberto Aguilar-Pineda
JMJosé Guillermo Méndez-Bermúdez
José Guillermo Méndez-Bermúdez
JAJosé Alejandre
José Alejandre

24 January 2018 in The Journal of Physical Chemistry B
Verified
Journal Article
Closed access
ENEdgar Núñez-Rojas
Edgar Núñez-Rojas
JAJorge Alberto Aguilar-Pineda
Jorge Alberto Aguilar-Pineda
ALAlexander Pérez de la Luz
Alexander Pérez de la Luz
EGEdith Nadir de Jesús González
Edith Nadir de Jesús González
JAJosé Alejandre
José Alejandre

Verified
Journal Article
Open access
PDF file
JAJorge Alberto Aguilar-Pineda
Jorge Alberto Aguilar-Pineda
MAMazen Albaghdadi
Mazen Albaghdadi
WJWanlin Jiang
Wanlin Jiang
KLKarin Jannet Vera López
Karin Jannet Vera López
RNRita Milagros Nieto-Montesinos
Rita Milagros Nieto-Montesinos
CCchristian lino cardenas
christian lino cardenas
Emerging evidence suggests that males are more susceptible to severe infection by the SARS-CoV-2 virus than females. A variety of mechanisms may underlie the observed gender-related disparities including differences in sex hormones. However, the precise mechanisms by which female sex hormones may provide protection against SARS-CoV-2 infectivity remains unknown. Here we report new insights into the molecular basis of the interactions between the SARS-CoV-2 spike (S) protein and the human ACE2 receptor. We further report that glycosylation of the ACE2 receptor enhances SARS-CoV-2 infectivity. Importantly, estrogens can disrupt glycan–glycan interactions and glycan–protein interactions between the human ACE2 and the SARS-CoV-2 thereby blocking its entry into cells. In a mouse model of COVID-19, estrogens reduced ACE2 glycosylation and thereby alveolar uptake of the SARS-CoV-2 spike protein. These results shed light on a putative mechanism whereby female sex hormones may provide protection from developing severe infection and could inform the development of future therapies against COVID-19.

3 August 2015 in Molecular Physics
Verified
Journal Article
Closed access
JAJorge Alberto Aguilar-Pineda
Jorge Alberto Aguilar-Pineda
GMG. Arlette Méndez-Maldonado
G. Arlette Méndez-Maldonado
ENEdgar Núñez-Rojas
Edgar Núñez-Rojas
JAJosé Alejandre
José Alejandre

28 January 2022 in Molecules
Verified
Journal Article
Open access
PDF file
Luis Daniel Goyzueta-MamaniLuis Daniel Goyzueta-Mamani
Luis Daniel Goyzueta-Mamani
Haruna L. Barazorda-CcahuanaHaruna L. Barazorda-Ccahuana
Haruna L. Barazorda-Ccahuana
Miguel Angel Chavez FumagalliMiguel Angel Chavez Fumagalli
Miguel Angel Chavez Fumagalli
KAKarla L. F. Alvarez
Karla L. F. Alvarez
JAJorge Alberto Aguilar-Pineda
Jorge Alberto Aguilar-Pineda
CCchristian lino cardenas
christian lino cardenas
Background: Despite research on the molecular bases of Alzheimer’s disease (AD), effective therapies against its progression are still needed. Recent studies have shown direct links between AD progression and neurovascular dysfunction, highlighting it as a potential target for new therapeutics development. In this work, we screened and evaluated the inhibitory effect of natural compounds from native Peruvian plants against tau protein, amyloid beta, and angiotensin II type 1 receptor (AT1R) pathologic AD markers. Methods: We applied in silico analysis, such as virtual screening, molecular docking, molecular dynamics simulation (MD), and MM/GBSA estimation, to identify metabolites from Peruvian plants with inhibitory properties, and compared them to nicotinamide, telmisartan, and grapeseed extract drugs in clinical trials. Results: Our results demonstrated the increased bioactivity of three plants’ metabolites against tau protein, amyloid beta, and AT1R. The MD simulations indicated the stability of the AT1R:floribundic acid, amyloid beta:rutin, and tau:brassicasterol systems. A polypharmaceutical potential was observed for rutin due to its high affinity to AT1R, amyloid beta, and tau. The metabolite floribundic acid showed bioactivity against the AT1R and tau, and the metabolite brassicasterol showed bioactivity against the amyloid beta and tau. Conclusions: This study has identified molecules from native Peruvian plants that have the potential to bind three pathologic markers of AD.